Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,674.80
+31.80 (1.94%)
May 11, 2026, 3:30 PM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 311.5 billion as of May 11, 2026. Its market cap has increased by 49.61% in one year.
Market Cap
311.50B
Enterprise Value
325.50B
Revenue
92.16B
Ranking
n/a
PE Ratio
33.69
Stock Price
1,674.80
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 311.50B, an increase of 21.23%. That is a compound annual growth rate of 11.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 311.50B | 20.42% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 668.43B |
| Laurus Labs | 663.11B |
| Ipca Laboratories | 395.80B |
| Ajanta Pharma | 384.45B |
| Gland Pharma | 313.76B |
| Wockhardt | 266.08B |
| Piramal Pharma | 243.97B |
| NATCO Pharma | 206.91B |